Nicole Rusaw-George
Directeur Financier/CFO chez LIMINAL BIOSCIENCES INC.
Postes actifs de Nicole Rusaw-George
Sociétés | Poste | Début | Fin |
---|---|---|---|
LIMINAL BIOSCIENCES INC. | Directeur Financier/CFO | 02/03/2022 | - |
Historique de carrière de Nicole Rusaw-George
Anciens postes connus de Nicole Rusaw-George
Sociétés | Poste | Début | Fin |
---|---|---|---|
COPLAND ROAD CAPITAL CORPORATION | Directeur Financier/CFO | 01/10/2019 | 09/06/2022 |
IONIC BRANDS CORP. | Directeur Financier/CFO | 01/06/2021 | 13/12/2021 |
NUVO PHARMACEUTICALS INC. | Directeur Financier/CFO | 01/08/2017 | - |
NEUPATH HEALTH INC. | Directeur/Membre du Conseil | 01/04/2019 | - |
Directeur Financier/CFO | 01/04/2019 | - | |
Secrétaire Général | - | - | |
TRANSITION THERAPEUTICS INC | Directeur Financier/CFO | 13/12/2011 | - |
Corporate Officer/Principal | 04/07/2008 | 13/12/2011 |
Formation de Nicole Rusaw-George
Brock University | Undergraduate Degree |
Statistiques
Internationale
Canada | 7 |
Etats-Unis | 2 |
Opérationnelle
Director of Finance/CFO | 6 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
COPLAND ROAD CAPITAL CORPORATION | Process Industries |
IONIC BRANDS CORP. | Producer Manufacturing |
LIMINAL BIOSCIENCES INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Transition Therapeutics, Inc.
Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
Nuvo Pharmaceuticals, Inc.
Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
Klinik Health Ventures Corp.
Klinik Health Ventures Corp. Financial ConglomeratesFinance Klinik Health Ventures Corp. operates as a capital pool company. The company was founded on April 17, 2019 and is headquartered in Toronto, Canada. | Finance |
- Bourse
- Insiders
- Nicole Rusaw-George
- Expérience